Polyphenols from Euphorbia pekinensis Inhibit AGEs Formation In Vitro and Vessel Dilation in Larval Zebrafish In Vivo

Abstract

To identify active compounds in the roots of Euphorbia pekinensis for treatment of diabetic complications, an active column fraction from a 70% EtOH extract of E. pekinensis root was purified by preparative reversed-phase high-performance liquid chromatography, leading to the isolation of a new ellagic acid derivative, 3,3′-di-O-methylellagic acid 4-O-(6ʺ-O-galloyl)-β-D-galactopyranoside (1), along with three known compounds, geraniin (2), 3,3′-di-O-methylellagic acid 4-O-β-D-xylopyranoside (3), and ellagic acid 3,3′-dimethyl ether (4). The structure of the new compound was established by extensive spectroscopic studies and chemical evidence. The inhibitory effects of isolated compounds 1–4 on advanced glycation end-products (AGEs) formation were examined. All compounds exhibited considerable inhibition of AGEs formation and IC₅₀ values of 0.41 – 12.33 µM, compared with those of the positive controls aminoguanidine (IC₅₀ = 1122.34 µM) and quercetin (IC₅₀ = 27.80 µM). In addition, the effects of 2 and 4 on the dilation of hyaloid-retinal vessels induced by high glucose (HG) in larval zebrafish were investigated; both compounds significantly reduced the HG-induced dilation of hyaloid-retinal vessels relative to the HG-treated control group.

Key words

Euphorbia pekinensis - Euphorbiaceae - polyphenols - diabetic complications - advanced glycation end-products - vessel dilation

• References

• 1 Chevallier A. The Encyclopedia of medicinal Plants. London: Dorling Kindersley; 1996
• 2 Yeung H. Handbook of Chinese Herbs and Formulas. Los Angeles: Institute of Chinese Medicine; 1985
• 3 Mucsi I, Molnar J, Hohmann J, Redei D. Cytotoxicities and anti-herpes simplex virus activities of diterpenes isolated from Euphorbia species. Planta Med 2001; 67: 672-674
• 4 Corea G, Fattorusso E, Lanzotti V, Motti R, Simon PN, Dumontet C, Di Pietro A. Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A. J Med Chem 2004; 47: 988-992
• 5 Sosath S, Ott HH, Hecker E. Irritant principles of the spurge family (Euphorbiaceae). XIII. Oligocyclic and macrocyclic diterpene esters from latices of some Euphorbia species utilized as source plants of honey. J Nat Prod 1988; 51: 1062-1074
• 6 Ahn BT, Zhang BK, Lee SC, Kim JG, Ro JS, Lee KS. Phenolic compounds of aerial parts of Euphorbia pekinensis . Yakhak Hoeji 1996; 40: 170-176
• 7 Ahn BT, Kang SS. Phenolic compounds from aerial parts of Euphorbia pekinensis (II). Korean J Pharmacogn 1996; 27: 142-145
• 8 Kong LY, Min ZD. Studies on the chemical constituents of roots of Euphorbia pekinensis . Acta Pharm Sin 1996; 31: 524-529
• 9 Ahn MJ, Kim CY, Lee JS, Kim TG, Kim SH, Lee CK, Lee BB, Shin CG, Huh H, Kim J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis . Planta Med 2002; 68: 457-459
• 10 Kong LY, Li Y, Wu XL, Min ZD. Cytotoxic diterpenoids from Euphorbia pekinensis . Planta Med 2002; 68: 249-252
• 11 Liang QL, Dai CC, Jiang JH, Tang YP, Duan JA. A new cytotoxic casbane diterpene from Euphorbia pekinensis . Fitoterapia 2009; 80: 514-516
• 12 Shao FG, Bu R, Zhang C, Chen CJ, Huang J, Wang JH. Two new casbane diterpenoids from the roots of Euphorbia pekinensis . J Asian Nat Prod Res 2011; 13: 805-810
• 13 Hou P, Zeng Y, Ma B, Bi K, Chen X. A new cytotoxic cembrane diterpene from the roots of Euphorbia pekinensis Rupr. Fitoterapia 2013; 90: 10-13
• 14 El-Toumy SAA, Rauwald HW. Two new ellagic rhamnosides from Punica granatum heartwood. Planta Med 2003; 69: 682-684
• 15 Pakulski G, Budzianowski J. Ellagic acid derivatives and naphthoquinones of Dionaea muscipula from in vitro cultures. Phytochemistry 1996; 41: 775-778
• 16 Lee HW, Oh CH, Geyer A, Pfleiderer W, Park YS. Characterization of a novel unconjugated pteridine glycoside, cyanopterin, in Synechocystis sp. PCC 6803. Biochim Biophys Acta 1999; 1410: 61-70
• 17 Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986; 232: 1629-1632
• 18 Skovborg F, Nielsen AV, Lauritzen E, Hartkopp O. Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 1969; 18: 292-298
• 19 Wei M, Gaskill SP, Haffner SM, Stern MP. Effect of diabetes and level of glycemia on all-cause and cardiovascular mortality: The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-1172
• 20 Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937-942
• 21 Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820
• 22 Takenaka K, Yamagishi S, Matsui T, Nakamura K, Imaizumi T. Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr Neurovasc Res 2006; 3: 73-77
• 23 Reddy VP, Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov Today 2006; 11: 646-654
• 24 Jang DS, Yoo NH, Kim NH, Lee YM, Kim CS, Kim J, Kim JH, Kim JS. 3,5-Di-O-caffeoyl-epi-quinic acid from the leaves and stems of Erigeron annuus inhibits protein glycation, aldose reductase, and cataractogenesis. Biol Pharm Bull 2010; 33: 329-333
• 25 Yoo NH, Jang DS, Lee YM, Jeong IH, Cho JH, Kim JH, Kim JS. Anthraquinones from the roots of Knoxia valerianoides inhibit the formation of advanced glycation end products and rat lens aldose reductase in vitro . Arch Pharm Res 2010; 33: 209-214
• 26 Lee IS, Kim YJ, Jung SH, Kim JH, Kim JS. Flavonoids from Litsea japonica inhibit AGEs formation and rat lense aldose reductase in vitro and vessel dilation in zebrafish. Planta Med 2017; 83: 318-325